Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01109108 · ClinicalTrials.gov registry record
Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 9,000
- Enrollment target
NCT01109108 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 9,000 participants.
The verdict
NCT01109108 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 9,000 participants
- Enrollment target
Study Summary
The specific aim is to evaluate the impact of PCV13 as administered in the pediatric primary care clinic at Boston medical center on the serotype specific carriage of Streptococcus pneumoniae in children \< 5. Specifically the investigators will measure the decline in vaccine serotypes, the proportion of children receiving vaccine required to achieve 50% reduction in serotype specific carriage and the correlation between immunogenicity of the specific serotypes and decline in carriage. The study has been extended to complete 5 years of surveillance to determine the new SP serotype distribution at the time presumably a new equilibrium has been achieved.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,000 participants |
| Start Date | 2010-04 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01109108
The ClinicalTrials.gov registry entry for NCT01109108 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01109108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01109108 about?
NCT01109108 is a clinical study titled "Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage". The specific aim is to evaluate the impact of PCV13 as administered in the pediatric primary care clinic at Boston medical center on the serotype specific carriage of Streptococcus pneumoniae in children \< 5. Specifically the investigators will measure the decline in vaccine serotypes, the proport...
What is the current status of trial NCT01109108?
This trial is currently completed. The enrollment target is 9,000 participants. The study started on 2010-04. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT01109108?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.